Just thoughts.
The ann that announced a trial at SVH had no positive effect because the market already knows the product is an effective gamechanger. While communicating with holders is highly commendable it was probably better not to post a gap filler but instead provide something of substance.
Announcing distribution deals has already been made. What we need is translation to sales. The demand is there. The ability to supply to the demand is unclear. Maybe a notice alongside a new sale that tells us the supply and distribution is enhanced by existing capability improvement, partnership or subcontract.
- Forums
- ASX - By Stock
- Ann: Rhinoswab clinical trial approved at St Vincent's Hospital
Just thoughts.The ann that announced a trial at SVH had no...
-
- There are more pages in this discussion • 24 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RNO (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
EQN
EQUINOX RESOURCES LIMITED.
Zac Komur, MD & CEO
Zac Komur
MD & CEO
SPONSORED BY The Market Online